|
|
An Analysis of the Efficacy of Omeprazole Combined with Intestinal Microecological Regulator in the Treatment of Neonatal Necrotizing Enterocolitis |
YANG Xue, ZHAO Xujing |
Yuncheng Central Hospital, Shanxi Yuncheng 044000, China |
|
|
Abstract Objective: To analyze the therapeutic effect of omeprazole combined with intestinal microecological regulator on neonatal necrotizing enterocolitis (NEC). Methods: Children with NEC who came to the hospital for treatment between January 2016 and July 2021 were selected as the research subjects, and they were divided into observation group and control group according to the principles of non-randomized clinical concurrent control and voluntariness of family members. The children in the control group were treated with intestinal microecological regulator, and the children in the observation group were given omeprazole on the basis of the control group. The relief time of clinical symptoms and clinical efficacy after 3d of treatment were compared between the two groups of children. The intestinal flora, immune function and imaging manifestations of the two groups were compared before and after treatment. Results: The diarrhea relief time, abdominal distension relief time and relief time of irregular bowel movement during treatment of observation group were shorter than those of control group, and the clinical efficacy after 3 d of treatment was better than that of control group (all P<0.05). The intestinal flora counts (total number of intestinal bacteria, total number of cocci, total number of bacilli), proportion of CD4+ and CD4+/CD8+ ratio after 3 d of treatment in the two groups were increased compared with those before treatment, and the differences before and after treatment were greater in observation group than those in control group (all P<0.05). The levels of serum CRP and PCT in the two groups were lower after 3d of treatment than those before treatment, and the differences before and after treatment between observation group and control group were significant (all P<0.05). The improvement ratios of intestinal wall thickening and fixed intestinal loop shadow before and after treatment in observation group were higher than those in control group (all P<0.05), but there was no statistical significance in the improvement ratio of portal venous gas between the two groups before and after treatment (P>0.05). Conclusion: Omeprazole combined with intestinal microecological regulator can effectively improve the immunity, relieve the inflammatory response, shorten the course of disease, and promote the rehabilitation of children with NEC.
|
|
|
|
|
[1] 甘馨,毛健,李娟.新生儿坏死性小肠结肠炎的临床特点与结局分析[J].中国当代儿科杂志,2019,21(10):79~83. [2] 王静.新生儿坏死性小肠结肠炎发病机制研究进展[J].安徽医药,2019,23(6):1074~1077. [3] 云晓静,王东梅,白玉焕,等.艾司奥美拉唑镁肠溶片联合西沙必利对反流性食管炎的治疗效果[J].河北医学,2018,24(10):1719~1722. [4] 邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].人民卫生出版社,2011.336~339. [5] 郑跃杰,黄志华,刘作义,等.微生态制剂儿科应用专家共识(2010年10月)[J].中国实用儿科杂志,2011,8(1):20~23. [6] Denning N L,Prince J M.Neonatal intestinal dysbiosis in necrotizing enterocolitis[J].Molecular Medicine,2018,24(1):4~7. [7] 郝武娟,屠文娟.坏死性小肠结肠炎新生儿肠道菌群变化研究进展[J].中华实用儿科临床杂志,2018,33(17):1358. [8] Seghesio E,Geyter C D,Vandenplas Y.Probiotics in the prevention and treatment of necrotizing enterocolitis[J].Pediatric Gastroenterology Hepatology & Nutrition,2021,24(3):245~249. [9] 胡善雷,李广明,李玲,等.质子泵抑制剂对慢性肝病患者肠道微生态的影响[J].中国微生态学杂志,2020,08(3):314~316. [10] 陈坚强.奥美拉唑对大鼠反流性食管黏膜损伤后氧化应激及细胞增殖相关蛋白表达的影响[J].中国临床药理学杂志,2019,35(6):536~538,546. [11] 高雅丽,彭松.腹部X线检查在新生儿坏死性小肠结肠炎分型及预后中的价值[J].中国医学影像技术,2020,36(S1):44~47. |
|
|
|